TAVOLIMAB

UNII:	4LU9B48U4D
Formula:
Preferred Substance Name:	TAVOLIMAB
GSRS Full Record:	4LU9B48U4D i

1635395-25-3
HUMAN IGG1 KAPPA ANTI-HUMAN OX40 MONOCLONAL ANTIBODY MEDI0562
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSTNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, OX40, CD134)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-451) (CHIMERIC VH (MUS MUSCULUS IGHV3-8*02 -(IGHD)-HOMO SAPIENS IGHJ4*01) (8.7.15) (1- 121) -HOMO SAPIENS IGHG1*03, G1M3 (CH1 (122-219), HINGE (220-234), CH2 (235-344), CH3 (345-449), CHS (450-451)) (122-451)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (88.40%) -IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01, KM3 (108'-214')) DIMER (230-230'':233-233'')-BISDISULFIDE
MEDI0562
MEDI-0562
TAVOLIMAB [INN]
TAVOLIMAB [USAN]
TAVOLIMAB [WHO-DD]
TAVOLIXIZUMAB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TAVOLIMAB

Synonyms and Mappings

Resources